2021 | Frank L.J. Visseren*, François Mach*, Yvo M. Smulders†, David Carballo†, Konstantinos C. Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H. Davos, Illeana Desormais, Emanuele Di Angelantonio, Oscar H. Franco, Sigrun Halvorsen, F. D. Richard Hobbs, Monika Hollander, Ewa A. Jankowska, Matthias Michal, Simona Sacco, Naveed Sattar, Konstantinos P. Tsioufis, Ineke van Dis, Isabelle C. van Gelder, Christoph Wanner, Bryan Williams
The 2021 European Society of Cardiology (ESC) Guidelines on Cardiovascular Disease Prevention in Clinical Practice, developed by a Task Force with representatives from the ESC and 12 medical societies, provide comprehensive guidance on preventing atherosclerotic cardiovascular disease (ASCVD). The guidelines cover risk factor assessment, risk estimation, and risk communication, emphasizing the importance of a healthy lifestyle and effective risk factor treatments. They address specific populations, such as younger and older individuals, and those with diabetes, chronic kidney disease, and other comorbidities. The guidelines also offer recommendations for physical activity, nutrition, alcohol consumption, mental healthcare, smoking cessation, lipid management, blood pressure control, and antithrombotic therapy. Additionally, they highlight the need for an integrated, interdisciplinary approach to ASCVD prevention, including lifestyle modifications, psychosocial factors, and social determinants. The guidelines aim to support healthcare professionals in making informed decisions and improving patient outcomes.The 2021 European Society of Cardiology (ESC) Guidelines on Cardiovascular Disease Prevention in Clinical Practice, developed by a Task Force with representatives from the ESC and 12 medical societies, provide comprehensive guidance on preventing atherosclerotic cardiovascular disease (ASCVD). The guidelines cover risk factor assessment, risk estimation, and risk communication, emphasizing the importance of a healthy lifestyle and effective risk factor treatments. They address specific populations, such as younger and older individuals, and those with diabetes, chronic kidney disease, and other comorbidities. The guidelines also offer recommendations for physical activity, nutrition, alcohol consumption, mental healthcare, smoking cessation, lipid management, blood pressure control, and antithrombotic therapy. Additionally, they highlight the need for an integrated, interdisciplinary approach to ASCVD prevention, including lifestyle modifications, psychosocial factors, and social determinants. The guidelines aim to support healthcare professionals in making informed decisions and improving patient outcomes.